# A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors

> **NCT04397276** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 82 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** JNJ-70218902

## Key facts

- **NCT ID:** NCT04397276
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-10
- **Primary completion:** 2025-09-16
- **Final completion:** 2025-09-16
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04397276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04397276, "A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04397276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*